Expanding into Europe

PTJ Expanding into Europe A1

Cracking the EMA Code Expanding into Europe Expanding a Rare Disease drug’s marketing authorization into Europe can potentially increase a company’s net worth, but it’s not a guaranteed outcome. Here’s a breakdown of the factors involved: Potential Benefits Increased Market Size Europe represents a significant market with a large population. Expanding authorization allows the company […]